investigators include staining with IgM, and there may based recommendations. The treatment of idiopathic minimal be a spectrum of disease between minimal lesion and lesion disease in children has been extensively studied in ranIgM mesangial proliferative glomerulonephritis. Indeed, domized controlled trials, however, there is less information this is a potential cause of confusion because some stud- remission or restore steroid responsiveness (grade D). Large retrospective studies in adults suggest that therapeutic response is slower than in children, but adults experience fewer relapses and more prolonged remission. Tables 1, 2 , and 3 review the levels of evidence of Minimal lesion glomerulonephritis typically presents English language studies in children. with the acute onset of nephrotic syndrome, often following a viral upper respiratory tract infection. ComplicaTreatment of the first attack tions include thrombosis, acute renal failure, and infecRecommendation 1. Prednisone at 60 mg/m 2 per day tions such as cellulitis, peritonitis, and pneumonia [1] .
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TREATMENT OF MINIMAL LESION GLOMERULONEPHRITIS IN CHILDREN
(up to a maximum of 80 mg/day) for four to six weeks Older literature suggests that spontaneous remissions (grade A) and then 40 mg/m 2 of prednisone every other occur in children with minimal lesion disease, usually day for four to six weeks (grade A) are recommended. after many months of disease compared with a much Evidence. Minimal lesion accounts for more than 90% earlier remission time induced with corticosteroids [2] [3] [4] .
of cases of idiopathic nephrotic syndrome in young chilHistology demonstrates essentially normal-appearing dren. Uncontrolled studies in the 1950s demonstrated glomeruli on light microscopy, although there may be that more than 90% of children would respond to cortisome expansion of the mesangial matrix. Immunofluocosteroid treatment. The pioneering studies of the Interrescence is usually negative for immunoglobulins. Some national Study of Kidney Diseases in Children (ISKDC) settled on a regimen of 60 mg/m 2 /day prednisone, to a maximum of 80 mg/day for four weeks, followed by The European collaborative group, Arbeitsgemeina shorter course of initial treatment might be just as effective as the standard regimen. The APN performed schaft fur Padiatrische Nephrologie (APN), suggested that in the second four weeks of treatment, prednisone a randomized controlled study of their standard regimen (four weeks of daily prednisone plus four weeks of altergiven every second day might be more effective in preventing relapses. These two regimens were compared in nate-day prednisone) compared with a short-course group who received 60 mg/m 2 /day of prednisone until a randomized controlled study in a group of 48 frequently relapsing patients [8] . Patients receiving alternate-day the urine was clear of protein (about two weeks) and then took alternate-day prednisone until the serum albumin prednisone had an approximate 50% reduction in relapse rate compared with the controls receiving predninormalized (another two weeks). Although the shortcourse group initially received only half of the amount sone three days out of seven. This difference occurred during only the six months of the trial, whereas the later of prednisone, they relapsed twice as often and twice as soon, and ultimately received as much steroid as the relapse rate was similar. The investigators concluded that the alternate-day regimen was superior for the second standard treatment group [11] . The authors concluded that there was no benefit to the shorter therapy. four weeks of therapy and have recommended it even for the first attack of minimal lesion disease [9] .
Several years later, they examined whether longer initial therapy conferred added protection against relapse Most patients will clear their proteinuria by two weeks of therapy [10] . Investigators have questioned whether [12] . Here, children with a first attack were randomly [30] Steroid-dependent NS 29 6-8 week CTX CTX 3-5 mg/kg/day ϫ 6-8 weeks ϩ 42% relapse rate at one year; treated with alt day alt day Pred 21% still in CR at 3.5 years Pred and 6-8 or 12 24 12 week CTX CTX 3-5 mg/kg/day ϫ 12 weeks ϩ 8% relapse rate at one year; weeks CTX; retroalt day Pred 63% still in CR at 3.5 years spective analysis (Continued) allocated to a long treatment consisting of daily predniundergoing the standard regimen. This level 1 study demonstrated that the long-treatment patients were twice as sone for six weeks and alternate-day prednisone for six weeks, and the children were then compared with those likely to remain in remission compared with the patients receiving the standard regimen. Furthermore, fewer pafurther, or very rare, relapses. A relapse in the first six tients with the long initial therapy ultimately became months was predictive of further relapses for the next frequent relapsers [12] . Even though the total amount three years. Perhaps not surprisingly, the failure to of prednisone taken for the first attack was greater than achieve remission in the first eight weeks of therapy in the standard regimen, steroid side-effects were no predicted progression to renal failure in 21% of the chilmore severe. The benefit was that less steroids were dren. The authors suggest that more aggressive therapy subsequently taken because of the fewer relapses. A should be used to achieve remission in these children similar result was found by investigators in Japan in who are slow to respond; however, it is possible that the another level 1 study, in which children at first presentadelayed or lack of response to standard therapy itself is tion were randomized to either the ISKDC protocol or a marker for more aggressive disease [15] . a longer protocol involving a taper over five months.
In summary, the intensity of initial therapy for minimal Again, the longer treatment group had fewer relapses, lesion disease appears to determine the rate of subseand fewer of the patients became frequent relapsers. quent relapse and perhaps also the chances of becoming Although the long-treatment group took more prednia frequent relapser. The optimization point of initial sone, the cumulative dose over the entire period of foldose of prednisone with its cumulative toxicity, versus low-up was not different [13] . morbidity involved in relapse and its retreatment, apThe difficulty in determining the trade-off between a pears to lie at an initial treatment with daily prednisone cumulative steroid dose versus a relapse-free internal is for four to six weeks and a course of alternate-day predwell illustrated in a randomized ISKDC study that examnisone for four to six weeks. Alternatively, a tapering ined a long versus shorter steroid regimen in children who course can be given over several months. had relapsed within six months of their initial response. In this study, the long-treatment group received approxiTreatment of relapse mately twice as much prednisone as the other group, but Recommendation 2. For patients with minimal lesion stayed in remission for a mean of 3.27 months compared disease who relapse after initial treatment, prednisone with 1.48 months. In the end, it was not clear, even to should be given at 60 mg/m 2 per day (up to 80 mg/day) many of the investigators, whether the extra steroid was until the urine is protein free; then 40 mg/m 2 should be worth the longer duration of remission [14] .
given every other day for four weeks (grade A). A recent retrospective analysis of nearly 400 children Evidence. Most children will have a relapse of their with minimal lesion disease found that if the children nephrosis. The mean duration of corticosteroid therapy responded to the first eight weeks of therapy with comto clear the urinary protein is similar for the relapse plete remission and maintained remission over the next six months, the long-term outlook was excellent with no as for the initial attack [11] . However, the intensity of prednisone treatment for a first relapse had no influence Treatment of frequently relapsing minimal lesion disease on the subsequent relapse rate [14, 16] .
The current relapse regimen consists of 60 mg/m 2 /day Recommendation 3. Patients with minimal lesion dis-(up to 80 mg/day) of prednisone until the urine is free ease who relapse frequently should be treated with one of protein for three days, followed by four weeks of of these regimens: cyclophosphamide or chlorambucil alternate day prednisone at 40 mg/m 2 [9] . This regimen for eight weeks (discussed in the text; grade A); repeat is associated with fewer relapses in the first six months relapse therapy with prednisone (grade D); symptomatic of treatment, compared with administering prednisone treatment only (Na restriction, diuretics; grade D); longthree out of seven days in the second four weeks of term alternate-day prednisone (grade D); and/or levamitherapy [8] . The ISKDC demonstrated that treating a sole (discussed in the text; grade B). relapse for four weeks with daily prednisone rather than Treatment of steroid-dependent minimal just until the urine cleared of protein (average 12 days) lesion disease was associated with a more prolonged remission (3.27 vs. 1.48 months) but at the cost of double the amount Recommendation 4. Children with steroid-dependent of prednisone [14] . Because all patients in both groups minimal lesion disease should be treated with 2 mg/kg/ relapsed by eight months anyway, it is recommended to day of cyclophosphamide for 12 weeks (grade D) or 6 treat a relapse with daily prednisone only until the urine mg/kg/day of cyclosporine for children and 5 mg/kg/day is protein free or for a few more days, and then proceed for adults, with the duration being uncertain (grade A). with the tapering regimen as described earlier in this
Evidence. Ten to 20% of children will experience three or four steroid-sensitive attacks, and half will bearticle.
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come frequent relapsers or steroid dependent. Given the low doses (less than 0.3 mg/kg/day) as effective as high doses (more than 3.0 mg/kg/day) [23, 24] . The APN studcumulative toxicity associated with long-term corticosteroid therapy, treatment has evolved to include alkylating ied the effect of eight weeks of treatment with cyclophosphamide at 2 mg/kg/day versus chlorambucil at 0.15 mg/ agents, antimetabolites, and cyclosporine in these more difficult patient groups. A frequent relapser is a patient kg/day in 16 children with frequent relapsing and 34 children with steroid-dependent disease. In the frequent who responds to corticosteroid treatment but experiences two relapses within the first six months after the relapsers, the rate of relapse after treatment declined, although actual rates of relapse prior to therapy were initial response or has four relapses within any one year [17] . Up to one quarter of relapses in frequent relapsing not formally compared. In contrast, the eight weeks of treatment did not apparently benefit the steroid-depenminimal lesion may remit spontaneously [2] . Steroid dependency is defined as two consecutive relapses ocdent cohort, although once again, relapse rates were not compared statistically before and after alkylating curring during therapy or within 14 days of completing steroid therapy [16] . Therapeutic options for frequent therapy. There was no difference between chlorambucil and cyclophosphamide, although the numbers were relapsers include repeated relapse treatment with corticosteroid, prolonged tapering of alternate-day or daily small for that intergroup comparison [17] . In a subsequent prospective study, steroid-dependent patients steroid, or symptomatic treatment with salt restriction and diuretics. Unfortunately, there are no good studies (similar to the patients who failed the eight weeks of alkylating therapy previously) were instead given 12 to compare outcomes of these regimens. The repeated or prolonged use of corticosteroids in either frequently weeks of therapy with 2 mg/kg/day of cyclophosphamide. The 12 week group was compared retrospectively with relapsing or steroid-dependent children carries with it the risk of side-effects, including growth retardation, osthe steroid-dependent children who had received eight weeks of cyclophosphamide. The cumulative rate of susteoporosis, obesity, and cataracts.
tained remission was 67% in the 12 week trial compared with 22% in the 8 week trial. However, the children who Antimetabolites and alkylating agents received 12 weeks of cyclophosphamide were older than The ISKDC studied prednisone with placebo comthe historical cohort, who received eight weeks, and may pared with prednisone and azathioprine for primary nonhave had a better prognosis because of this age difference responders and for frequent relapsers. This treatment [25] . In contrast, a randomized controlled study from had no benefit for the steroid-resistant group (10 of Japan comparing 8 versus 12 weeks of cyclophosphamide whom ultimately showed focal sclerosis on renal biopsy) head-to-head in steroid-dependent nephrotic syndrome or for the frequent relapsers [18] .
found that 12 weeks did not confer any advantage. The Cyclophosphamide is more effective. A randomized relapse rate was similar in both groups and similar to controlled trial in children with frequently relapsing minthe eight-week treatment group of the APN [26] . The imal lesion disease showed a statistically significant debetter outcome with the 12 weeks may be confounded cline in relapse rate in those given cyclophosphamide in by the fact that the children were older and compared addition to prednisone, even though there were just 10 with historical controls. children in each group [19] . The same investigators then Other retrospective or observational studies have concompared two weeks of treatment and eight weeks of firmed the effectiveness of cyclophosphamide in fretreatment with cyclophosphamide in a randomized conquently relapsing or steroid-dependent nephrotic syntrolled trial in frequent relapsers. Two weeks of cyclodrome [27] [28] [29] [30] . phosphamide led to more prolonged remission compared with historical controls who received prednisone Cyclosporine alone, whereas eight weeks of cyclophosphamide was even more effective [20] . A level 1 ISKDC study of Very few of the studies of cyclosporine in pediatric nephrosis are controlled, and most are small [31] . The cyclophosphamide in frequent relapsers showed the clear superiority of cyclophosphamide and prednisone (48% first such study, in the late 1980s, found that cyclosporine treatment reduced relapses and total corticosteroid dose relapse after a mean of 22 months) compared with prednisone alone (88% relapse after a mean of 22 months) [32] . Subsequent uncontrolled studies found complete remissions in steroid-dependent or frequently relapsing [21]. Barratt et al extended their follow-up of cyclophosphamide in frequent relapsers to four years in a level 4 nephrotic syndrome, whereas many children were able to stop corticosteroids [33, 34] . The largest study involved study, which showed that the eight-week course conferred a prolonged benefit to these patients [22] .
65 children with nephrotic syndrome, 45 of whom had minimal lesion disease. These patients were classified as Chlorambucil led to prolonged steroid-free remission in children with frequently relapsing or steroid-depensteroid resistant if they did not show remission after just four weeks of daily corticosteroids followed by three dent (not steroid-resistant) nephrotic syndrome, with S-9 pulses of solumedrol. Of the 45 patients with minimal agents are as effective as cyclosporine and produce a longer remission. lesion, 21 entered complete remission on cyclosporine treatment in combination with prednisone. Seventeen of these patients remained in remission after a mean threeLevamisole year follow-up once stopping the cyclosporine, and most
The antihelminthic agent levamisole has immunomodpatients became steroid sensitive [35] . It may have been ulatory effects and has been used in a number of diseases, premature, however, to classify these children as steroid such as cancer. Levamisole has been used alone or in resistant after just four weeks of therapy. Some of the combination therapy in minimal lesion disease in chilpatients who went into remission with cyclosporine may dren. Unfortunately, few of these studies were either have actually been demonstrating a delayed response to randomized or controlled [39] . A level 5 study used 2.5 corticosteroid treatment.
mg/kg twice weekly in frequently relapsing minimal leMost patients experience relapses of their disease sion disease. Half of the children had already received when cyclosporine is tapered or discontinued, becoming other immunosuppressive agents besides prednisone, cyclosporine dependent in the same way they were once which confuses the issue. Sixteen of the 30 patients stayed steroid dependent [31] . Furthermore, with subsequent relapse free while on levamisole, but many relapsed courses of cyclosporine treatment, the patients appear when it was stopped; however, the follow-up was short to become progressively less responsive. [40] . A recent study from India used alternate-day levaIn one of the few randomized studies, children in their misole therapy in steroid-dependent nephrotic syndrome first year of nephrotic syndrome were randomized to once remission was obtained with corticosteroids. The receive low-dose prednisone and cyclosporine or highsubsequent relapse rate decreased from a mean of 3 per dose prednisone alone (in half of each group, this was year to 0.9 per year [41] . Other small studies found that instituted with their first presentation). Children in treatment with levamisole induced or maintained remisboth groups went into remission, and there was no differsion [42] [43] [44] . In one of only two controlled studies of ence in the duration of remission once treatment was levamisole in pediatric nephrotic syndrome, an increased stopped [36] .
remission rate compared with placebo was found, but When compared with alkylating agents, cyclosporine most children relapsed within three months of stopping was not as successful in maintaining a prolonged remislevamisole [45] . In the other controlled study, 21 of 33 sion in steroid-dependent nephrosis [31] . In a randompatients receiving levamisole were still in remission comized controlled trial in both adults and children, cyclopared with 12 of 28 patients receiving no treatment, a phosphamide and cyclosporine were equally successful nonsignificant difference [46] . in inducing remission in steroid-dependent and freLevamisole is well tolerated. The side effects noted quently relapsing nephrotic syndrome. However, remisinclude neutropenia, rash, and liver toxicity [47] . Howsions lasted longer in the group that received the alkylatever, a review of the literature reveals no new largeing agent [37] .
scale studies using this agent in nephrosis of children in A recent uncontrolled retrospective study of the use the last few years. Perhaps others find this agent less of cyclosporine (2.5 to 5.0 mg/kg/day starting dose) in effective than published trials suggest; otherwise, it is steroid-dependent and steroid-resistant nephrosis in chilunclear why this agent has not been more widely acdren (some of whom had focal sclerosis) reported good cepted for this indication. results. There was halving of the steroid dependence in the first group and restoration of steroid responsiveness Treatment of steroid-resistant minimal lesion disease in approximately one fourth of the patients in the latter Recommendation 5. Management of steroid-resistant group. After a median follow-up of 7.5 years in the steminimal lesion disease can include rebiopsy to rule out roid-dependent cohort and 5.0 years in the steroid-resisfocal sclerosis (grade D), cyclophosphamide 2 mg/kg/ tant group, there was no change in plasma creatinine day ϫ 12 weeks (grade D), or cyclosporine at 6 mg/kg/day with the exception of some of the patients with focal for children or 5 mg/kg/day for adults for an uncertain sclerosis. A small number underwent follow-up renal duration (grade D). biopsy, and striped interstitial fibrosis and tubular atroEvidence. Patients with steroid-resistant minimal lephy were found, suggesting cyclosporine nephrotoxicity.
sion disease are the most difficult to treat. These patients However, these were not accompanied by changes in suffer the ill effects not only of corticosteroid toxicity, renal function (as judged by serum creatinine, though).
but of unremitting nephrosis with the attendant risks of The authors concluded that cyclosporine therapy in this sepsis, malnutrition, growth retardation, and thrombosis. setting was effective adjunctive therapy with minimal
The patient with steroid-resistant nephrotic syndrome long-term nephrotoxicity [38] .
also has a greater chance of progressive renal insuffiIn summary, for patients with steroid-dependent or frequently relapsing minimal lesion disease, alkylating ciency culminating in end-stage renal disease.
Studies in these children have been limited by small only in children, not in adults. The relapse rate was no different between the methylprednisolone and the oral numbers and short follow-up times. The only controlled prednisone group. Corticosteroid-related side effects study had eight children, four with minimal lesion and were more prevalent in the group receiving oral prednifour with focal sclerosis. The patients received eight sone. The investigators suggested that pulse methylpredweeks of cyclosporine in a randomized cross-over design; nisolone followed by low-dose oral prednisone was less there was no difference compared with no treatment [48] .
effective than the usual regimen of high-dose oral steGiven the paucity of evidence for cyclosporine, alkylroid, but was associated with less corticosteroid-related ating agents should be used first in children with freside effects. In patients who are at risk for corticosteroid quently relapsing, steroid-dependent, and steroid-resisside effects (for example, adult patients with osteoporotant minimal lesion disease. Cyclosporine should be sis), pulse steroid followed by low-dose oral prednisone reserved for those cases in which alkylating agents have might be more appropriate compared with longer term failed, especially in which there is unacceptable corticohigh-dose oral steroid treatment. No studies have disteroid toxicity and a holiday from prednisone is needed, rectly addressed this question [51] . to allow catch-up growth or puberty. Unfortunately, An uncontrolled level 4 study of alternate-day corticomost children continue to relapse when cyclosporine is steroid treatment in adults with idiopathic nephrotic synwithdrawn. The alternative, chronic cyclosporine therdrome used 60 to 120 mg of prednisone every other day apy, carries the risk of nephrotoxicity, with the extent for 9 to 12 months, followed by a gradual taper. Eightyof damage to the kidneys out of proportion to the rise three percent of patients with minimal lesion disease in serum creatinine. Serial renal biopsies have been recsustained a complete or partial remission. Although this ommended [49] . Progressive nephrotoxicity in children regimen was effective, the prolonged duration of therapy on long-term cyclosporine therapy may be avoided if the meant that the total amount of corticosteroids given was patients are kept volume expanded, low doses are used, at least as great as in patients receiving more convenand levels are closely monitored [50] .
tional therapy [52] .
Antimetabolites and alkylating agents TREATMENT OF MINIMAL LESION DISEASE IN ADULTS
Few studies have examined antimetabolites or alkylating agents in adults with minimal lesion disease. A level 5 Corticosteroids study of long-term azathioprine in patients with steroidFew randomized controlled studies have examined the resistant minimal lesion disease showed that all of the treatment of adults with minimal lesion disease (Tables  patients had remission of their nephrotic syndrome and 4 and 5). Observational studies from the 1950s showed increased creatinine clearance by one year. Unforturapid remissions after corticosteroid treatment of adult nately, the patients had previously received very large patients with minimal lesion disease. No controlled clinidoses of steroids, and in this uncontrolled study, it is cal trial was undertaken until 1970 when Black, Rose, unclear whether the remission was actually a late effect and Brewer performed a multicenter controlled trial of of large doses of prednisone or whether this was just steroid treatment in 125 adult nephrotic patients, includspontaneous remission [53] . ing 31 patients with biopsy-proven "minimal lesion" disFew studies have examined the use of cyclophosphaease (it is possible that patients with stage 1 membranous mide without corticosteroids in adult patients with miniglomerulonephritis could have been included in this mal change disease. In one study, 2 of the 10 patients group) [3] . The treatment group received prednisone, at treated with cyclophosphamide alone went into remisleast 20 mg/day, for at least six months, compared with sion [54] . In another study, very high doses of cyclophosa control group. In the patients with minimal lesion disphamide were used alone in a heterogeneous group of ease, prednisone therapy gave an early and rapid deeight patients with minimal lesion disease. Their gonadal crease in proteinuria. Control patients showed a tenstatus was not followed. In this study, nine weeks of dency for remission of the proteinuria, although this therapy with this alkylating agent induced remission in occurred much more slowly. By two and a half years, seven of these patients by five months. After a mean the difference with respect to proteinuria and serum follow-up of six years, none of the patients relapsed. albumin concentrations was not statistically significant Once again, however, this is a level 6 study, and it is between the prednisone-treated and control group. difficult to make firm conclusions in a condition that has Another multicenter randomized trial examined a tendency to remit if followed long enough [55] . whether adults and children with minimal lesion disease Cyclosporine could be more effectively treated with pulse methylprednisolone compared with the usual treatment. The group Cyclosporine induces complete or partial remissions in adults with minimal lesion disease. Two level 1 studies receiving methylprednisolone reached remission sooner Pred ϩ AZA in tapered to 20 mg/day 2/8 changed to Pred ϩ AZA-one different primary GN's ϫ 8 weeks; Pred 20 improved, one did not mg/day ϩ 150 mg AZA/day ϫ 8 weeks Uldall [54] Observational CTX for 10 CTX 1.5 mg/kg/day, 2 patients received CTX only and went into adult ML titrated to WBC CR; 8 patients had PR or relapses on 2.5-24 months Pred, on CTX all went into CR or near CR. Alopecia and ovarian toxicity Idelson [77] Review of steroid rx in 28 ML Corticosteroids (dose?) CR or PR predictive of long-term renal various 1E adult GN's outcome, also persistence of normal renal function for at least 3 years predictive of good outcome Al-Khader Review of CTX alone for 8 CTX CTX 8 mg/kg body wt 7/8 CTX CR by 14 weeks (mean 10 weeks) [55] "adult" ML (ages and tapered to WBC 2/8 diuretic only group CR 13-68) c/w diuretics 8 diuretics spontaneously by 12 months. None of 9 alone CR's had relapses by 6 year F/U Cade [53] Steroid-resistant ML 13 Pred 60 mg/day ϫ 4 All 13 showed 9 proteinuria, 8 C Cr . All in given AZA weeks, then very slow CR, but took up to one year to respond. taper over months; if Effect of AZA or late effect of Pred? failed rx or frequent relapses that were failing Pred changed to AZA 2.0-2.5 mg/kg/ body wt ϫ years Lim [78] Idiopathic NS 11 ML Pred in various doses, 4/11 had spontaneous remission. Steroid ACTH or no rx induced CR in 5
Abbreviations are in Table 1. involving adults are multicenter studies from Italy. The of these steroid-resistant patients had focal sclerosis. Of the two adults studied with minimal change disease, one first is a randomized controlled study in steroid-resistant nephrotic syndrome comparing 5 mg/kg/day of cyclowent into complete remission, and the other had no response. The sample was too small to draw any conclusporine in adults and 6 mg/kg/day in children to placebo [56] . Corticosteroid resistance was defined as persistence sion. Of the six children with minimal change disease, four experienced reduction or remission of proteinuria, of nephrotic syndrome after six weeks of prednisone (1 mg/kg/day) for adults or five weeks of prednisone (60 mg/ and two had continuing nephrosis [56] . The other randomized, controlled trial involved pam 2 /day) for children. Unfortunately, eligibility included focal sclerosis in addition to minimal lesion disease. Most tients with steroid-dependent (as opposed to steroid- [60] NS resistant to Pred Ϯ 3 ML CsA 6-10 mg/kg/day 3/3 CR within one month. All CTX given CsA relapsed within 1-3 months (details of prior rx of stopping CsA. Remission not given) could be reinduced.
Abbreviations are in Table 1. resistant) nephrotic syndrome or frequently relapsing [37] . Once again, however, it is important to emphasize that there were only 11 adults altogether in this study. disease [37] . These patients were randomly allocated to 2.5 mg/kg/day of cyclophosphamide for eight weeks or
Other uncontrolled studies in adults show results similar to those in children, that is, there is a good initial 5 mg/kg/day of cyclosporine in adults (6 mg/kg/day in children) for up to 12 months. Patients had to be in response [57] but a disheartening relapse rate as the drug is tapered and discontinued [58] [59] [60] [61] [62] . remission already, and prednisone was tapered off by the first five weeks of the protocol. The majority of the In conclusion, the role of cyclosporine in minimal lesion disease may be (a) in frequently relapsing or steroidpatients were children (55 out of 64), but the results were similar through all ages. Unlike the previous study, dependent disease, in which a trial of cyclophosphamide has failed, (b) where cyclophosphamide is contraindithe majority of patients had minimal lesion disease (31 out of 34). The population was similar to the ones in cated or there are concerns about gonadal toxicity, (c) in steroid-dependent disease to allow a "steroid holiday" studies by the European and ISKDC groups discussed earlier. As in those reports, cyclophosphamide was quite for catch-up growth and puberty, or (d) in steroid-resistant disease. effective in producing a long-lasting remission. Two years after treatment, 63% of the cyclophosphamideCyclosporine can produce long-term nephrotoxicity, especially in adults whose underlying vascular disease is treated group were still in remission compared with 25% of those treated with cyclosporine. The authors recommore prevalent than in children. Patients with tubulointerstitial lesions may progress to end-stage renal disease mended that frequently relapsing or steroid-dependent patients be treated with cyclophosphamide first. If that more rapidly when given this agent [61] . Without further controlled studies, however, this interaction will be hard fails, then cyclosporine could be used as the next agent
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to tease out because the kind of nephrosis in which retrospective analyses, patients who develop acute renal cyclosporine is often tried, such as steroid-resistant minifailure are older, tend to be male, and are hypertensive mal lesion disease or focal sclerosis, is in itself associated with evidence of vascular disease [63, 64] . A recent rewith progression to renal failure.
view of all reports in the English medical literature found that the average age of patients with this complication Long-term outcome of adults with minimal was 58 years. The mean urine protein excretion was 11.6 lesion disease g/day, and the patients had a mean serum albumin of The long-term outcome of patients older than 15 has just 19 g/liter [65] . Acute renal failure occurred, on averbeen examined retrospectively [1, 4] . Adults with miniage, less than a month after onset of the nephrotic synmal lesion disease, in contrast to children, have equal drome and lasted an average of seven weeks [65] . Despite sex distribution. In addition, more of these adults had the prolonged course of renal failure, recovery almost hypertension, and there was more microscopic hematualways occurred. There is one report of five patients who ria. Furthermore, adults show an increased prevalence did not recover renal function [66] , but at least two of of diminished glomerular filtration rate, and there was these patients probably had focal sclerosis. Many had a significant mortality associated with this condition. In dye studies, and one patient refused dialysis and died the Guy's Hospital series of idiopathic nephrotic syn-(perhaps before renal function would have returned). drome in adults, 25% had minimal lesion disease, showOn renal biopsy, patients with acute renal failure have ing that this is a significant cause of idiopathic nephrotic more arteriosclerosis than those with preserved function syndrome in adults. Five of the 49 patients presented [64] . Acute tubular necrosis is the most prevalent finding with acute renal failure, and four of these needed dialysis but is not universally seen [64, 67] . Marked edema of (acute renal failure in minimal lesion disease is discussed the tubulointerstitium has been described in some cases later in this article) [4] . Three of the 49 patients had a [63] but is conspicuously absent in others [64] . spontaneous remission before therapy was given, supIn the original descriptions of acute renal failure, it porting the previous observation of Black, Rose, and was postulated that reduced plasma oncotic pressure led Brewer [3] . Seventy percent of patients relapsed, most to a contracted plasma volume. With the added insults them two or more times. This may have been related of vigorous diuresis or paracentesis, for example, the to a shorter course of prednisone that they received kidneys became critically underperfused, and ischemic compared with other studies. Complications of minimal acute tubular necrosis supervened [67] . lesion disease were similar to those seen in children, with This hypothesis has several weaknesses. As discussed, the exception of acute renal failure. Three patients had in patients with acute renal failure, acute tubular necrosis pulmonary emboli, and two patients developed cellulitis.
is found on renal biopsy no more than 60 to 70% of the A follow-up study was published 12 years later of 89 time [64] . The duration of renal failure is atypically long patients with a mean follow-up of 7.5 years [1] . Again, for acute tubular necrosis, suggesting that other factors the prevalence of hypertension and microscopic hematuare contributing to the renal compromise. ria was confirmed. Glomerular filtration rate was diminThere is little compelling clinical evidence for marked ished in 60% of patients. Patients who went into remisplasma volume depletion in patients who develop renal sion earlier also seemed to relapse earlier. In total, only failure [65] . Indeed, the patients who develop renal fail-56% of patients were still protein free at nine months ure have the highest blood pressures, compatible with and only 34% at two years. There was a much lower the presence of vascular disease [64] . Plasma volume reprelapse rate in these adults when they were given a course letion does not reliably reverse the renal failure [65, 68] . of cyclophosphamide. Sixty-three percent of the cycloImprovement in techniques to measure plasma volume phosphamide-treated patients were still in remission has led to the re-evaluation of the concept of plasma after 10 years of follow-up. These authors concluded that volume contraction in the nephrotic syndrome. Plasma adults had a lower and slower response to corticosteroids volume in patients with minimal lesion disease appears (but were given proportionately less prednisone per to be normal or even increased [69, 70] . The increased body weight compared with children). They sustained rather than decreased plasma volume may be, in part, a fewer relapses compared with children, and they seemed result of a parallel fall in oncotic pressure in the interstito have a more stable and sustained remission after a tial compartment of body water, which would decrease course of cyclophosphamide. Finally, hypertension, diflux of water out of the plasma compartment [71] . Furminished glomerular filtration rate, and acute renal failthermore, renal excretion of salt and water is decreased ure were all more prevalent in the adult population. in minimal lesion disease, which serves to keep the Acute renal failure as a complication of minimal plasma compartment expanded [72, 73] . lesion disease Lowenstein, Schacht, and Baldwin noted the lack of tubular necrosis in a retrospective review of 15 patients A small subset of patients develop frank acute renal failure as a complication of minimal lesion disease. In with minimal lesion disease complicated by acute renal bules and Bowman's space, leading to a decreased glomerular filtration rate [63] . If there is convincing clinical evidence of plasma volume depletion in a given patient (decreased jugular venous pressure, hypotension), it may be reasonable to try to normalize plasma volume with colloid, although this may occur only transiently [74, 75] . Advocates of the renal interstitial edema theory suggest diuretic treatment sufficient to effect a vigorous diuresis [63] . However, it is possible that the response to diuretics is simply a marker of a functioning kidney, rather than a treatment that restores function to an acutely failed kidney.
Recovery of renal function occurs in the majority of patients. The duration of renal failure is typically prolonged, and the endogenous renal function should be monitored while the patient is on dialysis.
SUMMARY
Among all of the glomerulonephritides in children, minimal lesion disease is one of the most common. This has made possible a large number of clinical trials, providing sufficient evidence for very clear treatment recommendations (Fig. 1) . Corticosteroid treatment is proven effective in this group, although relapses occur. In adults, however, a paucity of large randomized trials means that recommendations cannot easily be made. an increase in hydrostatic pressure in the proximal tu-
